About this trial
The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments.
Eligibility criteria
Qualifiers
Inclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors
Patient present with myopic or myopic and astigmatic error
Patient will be able to understand the patient information and willing to sign an informed consent
Patient will be willing to comply with all follow-up visits and the respective examinations
Disqualifiers
Exclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors
Trial design
Treatments tested in this trial
- PTK-PRK refractive treatment
Treatment groups
Sponsors and collaborators
London Vision Clinic
Lead sponsor
Optana GmbH
Collaborator